181 related articles for article (PubMed ID: 15166094)
1. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2.
Wang Y; Kodani E; Wang J; Zhang SX; Takano H; Tang XL; Bolli R
Circ Res; 2004 Jul; 95(1):84-91. PubMed ID: 15166094
[TBL] [Abstract][Full Text] [Related]
2. [COX-2 or nNOS mediates cardioprotection during the final stage of the late phase of ischemic preconditioning].
Xu Q; Tang B; Zhang N; Song L; Zhang Z; Chen Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Dec; 25(6):1411-4. PubMed ID: 19166220
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
[TBL] [Abstract][Full Text] [Related]
4. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte.
Wang Y; Guo Y; Zhang SX; Wu WJ; Wang J; Bao W; Bolli R
J Mol Cell Cardiol; 2002 Jan; 34(1):5-15. PubMed ID: 11812160
[TBL] [Abstract][Full Text] [Related]
5. Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism.
Jones WK; Flaherty MP; Tang XL; Takano H; Qiu Y; Banerjee S; Smith T; Bolli R
J Mol Cell Cardiol; 1999 Aug; 31(8):1469-81. PubMed ID: 10423345
[TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning.
Shinmura K; Xuan YT; Tang XL; Kodani E; Han H; Zhu Y; Bolli R
Circ Res; 2002 Mar; 90(5):602-8. PubMed ID: 11909825
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of cyclooxygenase-2 upregulation in late preconditioning.
Xuan YT; Guo Y; Zhu Y; Han H; Langenbach R; Dawn B; Bolli R
J Mol Cell Cardiol; 2003 May; 35(5):525-37. PubMed ID: 12738234
[TBL] [Abstract][Full Text] [Related]
8. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
Shi EY; Jiang XJ; Bai H; Nakajima Y
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.
Li Q; Guo Y; Xuan YT; Lowenstein CJ; Stevenson SC; Prabhu SD; Wu WJ; Zhu Y; Bolli R
Circ Res; 2003 Apr; 92(7):741-8. PubMed ID: 12702642
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
Shinmura K; Tang XL; Wang Y; Xuan YT; Liu SQ; Takano H; Bhatnagar A; Bolli R
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10197-202. PubMed ID: 10963682
[TBL] [Abstract][Full Text] [Related]
11. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.
Nagayama M; Niwa K; Nagayama T; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 1999 Nov; 19(11):1213-9. PubMed ID: 10566967
[TBL] [Abstract][Full Text] [Related]
12. Alpha-adrenergic receptor stimulation produces late preconditioning through inducible nitric oxide synthase in mouse heart.
Tejero-Taldo MI; Gursoy E; Zhao TC; Kukreja RC
J Mol Cell Cardiol; 2002 Feb; 34(2):185-95. PubMed ID: 11851358
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits.
Takano H; Manchikalapudi S; Tang XL; Qiu Y; Rizvi A; Jadoon AK; Zhang Q; Bolli R
Circulation; 1998 Aug; 98(5):441-9. PubMed ID: 9714095
[TBL] [Abstract][Full Text] [Related]
14. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.
Dawn B; Xuan YT; Guo Y; Rezazadeh A; Stein AB; Hunt G; Wu WJ; Tan W; Bolli R
Cardiovasc Res; 2004 Oct; 64(1):61-71. PubMed ID: 15364614
[TBL] [Abstract][Full Text] [Related]
15. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A.
Zhao L; Weber PA; Smith JR; Comerford ML; Elliott GT
J Mol Cell Cardiol; 1997 Jun; 29(6):1567-76. PubMed ID: 9220342
[TBL] [Abstract][Full Text] [Related]
16. In vivo study on cross talk between inducible nitric-oxide synthase and cyclooxygenase in rat gastric mucosa: effect of cyclooxygenase activity on nitric oxide production.
Uno K; Iuchi Y; Fujii J; Sugata H; Iijima K; Kato K; Shimosegawa T; Yoshimura T
J Pharmacol Exp Ther; 2004 Jun; 309(3):995-1002. PubMed ID: 14988416
[TBL] [Abstract][Full Text] [Related]
17. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
Patel HH; Hsu AK; Gross GJ
Life Sci; 2004 May; 75(2):129-40. PubMed ID: 15120566
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.
Bolli R; Shinmura K; Tang XL; Kodani E; Xuan YT; Guo Y; Dawn B
Cardiovasc Res; 2002 Aug; 55(3):506-19. PubMed ID: 12160947
[TBL] [Abstract][Full Text] [Related]
19. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
Zhang JH; Chen ZW; Wu Z
Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
[TBL] [Abstract][Full Text] [Related]
20. Xenon induces late cardiac preconditioning in vivo: a role for cyclooxygenase 2?
Weber NC; Frässdorf J; Ratajczak C; Grueber Y; Schlack W; Hollmann MW; Preckel B
Anesth Analg; 2008 Dec; 107(6):1807-13. PubMed ID: 19020121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
